Variant report
Variant | nsv997286 |
---|---|
Chromosome Location | chr4:59605553-59633187 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:1)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
(count:1 , 50 per page) page:
1
No. | Distal block | Cell Line | Cell type | Cell Stage |
---|---|---|---|---|
1 | chr4:59616982..59619599-chr6:27805611..27807692,2 | MCF-7 | breast: |
No data |
No data |
No data |
Variant related genes | Relation type |
---|---|
ENSG00000184348 | chromatin interactions |
ENSG00000233822 | chromatin interactions |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs368301479 | chr4:59614415-59614416 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
2 | rs532070943 | chr4:59614417-59614418 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
3 | rs192935276 | chr4:59614438-59614439 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
4 | rs4865362 | chr4:59614439-59614440 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
5 | rs17218343 | chr4:59614469-59614470 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
6 | rs536459444 | chr4:59614486-59614487 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
7 | rs554510714 | chr4:59614490-59614491 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
8 | rs548430810 | chr4:59614499-59614500 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
9 | rs569950153 | chr4:59614518-59614519 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
10 | rs17051426 | chr4:59614589-59614590 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs566755828 | chr4:59614594-59614595 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs552399036 | chr4:59614599-59614600 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
13 | rs570698678 | chr4:59614612-59614613 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
14 | rs73821028 | chr4:59614674-59614675 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
15 | rs13117539 | chr4:59614675-59614676 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
16 | rs55894705 | chr4:59614680-59614681 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
17 | rs79500346 | chr4:59614702-59614703 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
18 | rs574747380 | chr4:59614746-59614747 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
19 | rs3922040 | chr4:59614769-59614770 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
20 | rs527613500 | chr4:59614782-59614783 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
21 | rs188457370 | chr4:59614859-59614860 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
22 | rs575508956 | chr4:59614888-59614889 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
23 | rs546133759 | chr4:59614925-59614926 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
24 | rs75243572 | chr4:59614962-59614963 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
25 | rs573361603 | chr4:59614981-59614982 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
26 | rs368614882 | chr4:59615023-59615024 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
27 | rs116346302 | chr4:59615024-59615025 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
28 | rs114731244 | chr4:59615025-59615026 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
29 | rs115357467 | chr4:59615026-59615027 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
30 | rs557618752 | chr4:59615027-59615028 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
31 | rs541440224 | chr4:59615032-59615033 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
32 | rs528777713 | chr4:59615038-59615039 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
33 | rs530815060 | chr4:59615059-59615060 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
34 | rs552508417 | chr4:59615086-59615087 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
35 | rs540941113 | chr4:59615103-59615104 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
36 | rs528297150 | chr4:59615122-59615123 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
37 | rs191329123 | chr4:59615138-59615139 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
38 | rs185046748 | chr4:59615189-59615190 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
39 | rs367934481 | chr4:59615208-59615209 | Enhancers Active TSS | n/a | n/a | Overlapped CNVs | n/a |
40 | rs17827430 | chr4:59615238-59615239 | Enhancers Active TSS | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
41 | rs556931670 | chr4:59615247-59615248 | Enhancers Active TSS | n/a | n/a | Overlapped CNVs | n/a |
42 | rs568922623 | chr4:59615266-59615267 | Enhancers Active TSS | n/a | n/a | Overlapped CNVs | n/a |
43 | rs539699731 | chr4:59615301-59615302 | Enhancers Active TSS | n/a | n/a | Overlapped CNVs | n/a |
44 | rs190695643 | chr4:59615321-59615322 | Enhancers Active TSS | n/a | n/a | Overlapped CNVs | n/a |
45 | rs181983269 | chr4:59615336-59615337 | Enhancers Active TSS | n/a | n/a | Overlapped CNVs | n/a |
46 | rs540455342 | chr4:59615337-59615338 | Enhancers Active TSS | n/a | n/a | Overlapped CNVs | n/a |
47 | rs11133583 | chr4:59615359-59615360 | Enhancers Active TSS | n/a | n/a | Overlapped CNVs | n/a |
48 | rs574447075 | chr4:59615365-59615366 | Enhancers Active TSS | n/a | n/a | Overlapped CNVs | n/a |
49 | rs13118635 | chr4:59615386-59615387 | Enhancers Active TSS | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
50 | rs186976158 | chr4:59615422-59615423 | Enhancers Active TSS | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Gastrointestinal stromal cancer | 16982739 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Chordoma | 21602918 | CNVD |
HIV/AIDS | 22032296 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Neuroblastoma | 18923191 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Intellectual disability | 22102821 | CNVD |
Autism | 22495311 | CNVD |
Breast cancer | 21858162 | CNVD |
Small bowel adenocarcinoma | 21586687 | CNVD |
Gastric cancer | 21586687 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Non-small cell lung cancer | 21829676 | CNVD |
Melanoma | 18172304 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Lung cancer | 18438408 | CNVD |
Renal cell carcinoma | 18194544 | CNVD |
Breast cancer | 17603634 | CNVD |
Glioblastoma multiforme | 21922591 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Parkinson disease | 21956041 | CNVD |
Mental retardation | 20522426 | CNVD |
delayed speech | 20522426 | CNVD |
growth disorder | 20522426 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Myxofibrosarcoma | 16751306 | CNVD |
Esophageal squamous carcinoma | 18350619 | CNVD |
Parkinson disease | 18923514 | CNVD |
Non-syndromic sensorineural hearing loss | 15273396 | CNVD |
Cancer | 21183584 | CNVD |
Breast cancer | 16272173 | CNVD |
Multiple myeloma | 16616336 | CNVD |
Colorectal cancer | 19359472 | CNVD |
Malignant mesothelioma | 18160781 | CNVD |
Medulloblastoma | 18056178 | CNVD |
Multiple myeloma | 17077331 | CNVD |
Pleural malignant mesothelioma | 18160781 | CNVD |
Primary mediastinal b-cell lymphoma | 17728785 | CNVD |
Oral squamous cell carcinoma | 17134496 | CNVD |
4q-syndrome | 17576883 | CNVD |
Cancer | 21637783 | CNVD |
Non-syndromic sensorineural hearing loss | 18471307 | CNVD |
Colorectal cancer | 20709793 | CNVD |
Muscular dystrophy | 21149563 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 21264507 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Liposarcoma | 21253554 | CNVD |
Oligodendroglial tumors | 17285580 | CNVD |
Cervical cancer | 21062161 | CNVD |
Metanephric adenoma | 20802469 | CNVD |
Breast cancer | 16608533 | CNVD |
Colorectal cancer | 16272173 | CNVD |
Adenoid cystic carcinoma | 18698036 | CNVD |
Lung cancer | 19208797 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Wilms tumour | 21544195 | CNVD |
Breast cancer | 21785460 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Acute myeloid leukemia | 21251322 | CNVD |
Acute lymphoblastic leukemia | 21339820 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Intellectual disability | 22045946 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
Acute monocytic leukemia | 16498392 | CNVD |
Prostate cancer | 16573809 | CNVD |
Osteoporosis | 18992858 | CNVD |
Basal cell lymphoma | 17170743 | CNVD |
Follicular lymphoma | 17170743 | CNVD |
Glioma | 20126413 | CNVD |
Non-syndromic sensorineural hearing loss | 21293372 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr4:59614400-59616800 | Enhancers | Fetal Intestine Small | intestine |
2 | chr4:59614600-59615400 | Enhancers | hESC Derived CD56+ Mesoderm Cultured Cells | ES cell derived |
3 | chr4:59615200-59615800 | Enhancers | Breast Myoepithelial Primary Cells | Breast |
4 | chr4:59615200-59615800 | Enhancers | Fetal Intestine Large | intestine |
5 | chr4:59615200-59616000 | Active TSS | Rectal Mucosa Donor 29 | rectum |
6 | chr4:59615400-59616000 | Active TSS | Duodenum Mucosa | Duodenum |
7 | chr4:59623200-59623800 | Active TSS | A549 | lung |
8 | chr4:59626600-59627000 | Enhancers | A549 | lung |
9 | chr4:59626600-59627800 | Enhancers | Pancreatic Islets | Pancreatic Islet |
10 | chr4:59632800-59633200 | Enhancers | iPS-15b Cell Line | embryonic stem cell |
11 | chr4:59633000-59633800 | Enhancers | A549 | lung |